https://www.selleckchem.com/products/cu-cpt22.html
To conduct a systematic review and meta-analysis of randomized controlled trials on the clinical efficacy and safety of prophylactic tranexamic acid (TXA) versus control (normal saline/no treatment) during myomectomy. Six databases were screened from inception until 21-February-2022. The eligible studies were assessed for risk of bias. The outcomes were summarized as mean difference (MD) and risk ratio (RR) with 95% confidence intervals (CI) in a random-effects model. Seven studies, comprising eight arms and 571 patients (TXA=304 patie
Gefällt mir
Kommentar
Teilen
